Debasish Sundi, MD serves as Assistant Professor of Urology at The Ohio State University James Cancer Center. Dr. Sundi's primary research interest is bladder cancer immunotherapy, specifially in the role of immune suppressor cells in conferring resistance to checkpoint blockade. Clinically, Dr. Sundi specializes in urologic oncology, providing surgical care for patients with cancers of the bladder, kidney, and prostate.